v3.25.2
Stockholders' Equity - Additional Information (Detail)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 05, 2025
USD ($)
$ / shares
shares
Dec. 17, 2024
USD ($)
$ / shares
shares
Aug. 15, 2023
USD ($)
shares
Sep. 27, 2022
USD ($)
$ / shares
shares
Apr. 06, 2022
USD ($)
$ / shares
shares
Oct. 18, 2021
USD ($)
PrivatePlacement
$ / shares
shares
Oct. 05, 2021
USD ($)
$ / shares
shares
Feb. 29, 2024
shares
Jun. 30, 2023
USD ($)
May 31, 2022
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2025
shares
Mar. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
shares
Stockholders Equity [Line Items]                                
Stock issuance cost | $                           $ 590,000 $ 0  
Share based compensation options grants in the period                           2,760,150    
Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period                       20,010,000   20,010,000    
Performance-Based Vesting Stock Options [Member]                                
Stockholders Equity [Line Items]                                
Share based compensation options grants in the period               832,250                
PSOs [Member]                                
Stockholders Equity [Line Items]                                
Share-based compensation options vested (in shares)                           642,160    
Private Placement [Member] | Investor [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock             9,852,138                  
Private Placement [Member] | Investor [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period             2,373,201                  
Warrants to purchase aggregate shares of common stock             4,746,402                  
Private Placement [Member] | Investor [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Exercise price per share of warrants | $ / shares             $ 0.001                  
Private Placement [Member] | Investor [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                                
Stockholders Equity [Line Items]                                
Combined price of each shares | $ / shares             1.62                  
Private Placement [Member] | Investor [Member] | Pre-funded Warrant and Accompanying Common Stock Warrants [Member]                                
Stockholders Equity [Line Items]                                
Combined price of each shares | $ / shares             $ 1.619                  
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $             $ 11,800,000                  
Private Placement [Member] | Investor [Member] | Common Stock Warrants                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock             7,299,270                  
Exercise price per share of warrants | $ / shares             $ 1.37                  
Warrants expiration date             Apr. 05, 2025                  
Private Placement [Member] | Investor [Member] | Warrant [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock             7,299,270                  
Warrants expiration date             Oct. 05, 2028                  
Private Placement [Member] | New Enterprise Associates 16, L.P [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock           3,703,704                    
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $           $ 13,700,000                    
Number of private placements | PrivatePlacement           2                    
Stock issuance cost | $           $ 1,100,000                    
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period           1,851,852                    
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                                
Stockholders Equity [Line Items]                                
Common stock warrants exercise price and expiration date description                           The accompanying common stock warrants have an exercise price of $1.37 per share and became exercisable immediately upon issuance. Of the accompanying common stock warrants, warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock were scheduled to expire on April 18, 2025, and warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock will expire on October 18, 2028. On April 17, 2025, NEA exercised all of the warrants that would have expired on April 18, 2025. None of the accompanying common stock warrants issued to NEA in the private placement that expire on October 18, 2028 have been exercised.    
Combined price of each shares | $ / shares           $ 1.62                    
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $           $ 3,000,000                    
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock Warrants                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock           1,851,852                    
Exercise price per share of warrants | $ / shares           $ 1.37                    
Warrants expiration date           Apr. 18, 2025                    
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Warrant [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock           1,851,852                    
Warrants expiration date           Oct. 18, 2028                    
Private Placement [Member] | Securities Purchase Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period         4,580,526                      
Combined price of each shares | $ / shares         $ 1.90                      
Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Combined price of each shares | $ / shares         $ 1.899                      
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $         $ 55,000,000                      
Exercise price per share of warrants | $ / shares         $ 0.001                      
September 2022 Offering [Member] | Underwriting Agreement [Member]                                
Stockholders Equity [Line Items]                                
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $       $ 58,100,000                        
Warrants initial closing date       Sep. 27, 2022                        
September 2022 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period       14,252,670                        
Combined price of each shares | $ / shares       $ 1.93                        
Exercise price per share of warrants | $ / shares       $ 0.001                        
September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock       14,247,330                        
Combined price of each shares | $ / shares       $ 1.929                        
Options to purchase additional shares       1,600,428                        
December 2024 Offering [Member] | Underwriting Agreement [Member]                                
Stockholders Equity [Line Items]                                
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $   $ 50,000,000                            
December 2024 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period   12,500,000                            
Combined price of each shares | $ / shares   $ 4                            
June 2025 Offering [Member] | Underwriting Agreement [Member]                                
Stockholders Equity [Line Items]                                
Gross proceeds from issuance of underwritten offering | $ $ 115,100,000                              
June 2025 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period 17,400,000                              
Combined price of each shares | $ / shares $ 5.75                              
Maximum [Member] | Private Placement [Member] | Investor [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock             4,926,069                  
Maximum [Member] | Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock         24,379,673                      
Maximum [Member] | September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock       4,275,000                        
Maximum [Member] | June 2025 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock 2,610,000                              
2020 ATM Sales Agreement [Member]                                
Stockholders Equity [Line Items]                                
Aggregate offering price of common stock which may issue and sell under agreement | $                   $ 50,000,000 $ 12,000,000   $ 62,000,000      
Sale of stock during the period     4,333,394                          
Proceeds from issuance of common stock | $     $ 12,700,000                          
Estimated commissions and allocated fees | $     $ 1,000,000                          
Proceeds from issuance of common stock, preferred stock, debt securities, units and or warrants | $                 $ 200,000,000              
2023 ATM Sales Agreement [Member]                                
Stockholders Equity [Line Items]                                
Aggregate offering price of common stock which may issue and sell under agreement | $                 $ 75,000,000              
Sale of stock during the period                           0   4,498,065
Proceeds from issuance of common stock | $                               $ 14,600,000
Estimated commissions and allocated fees | $                               $ 500,000